NEW YORK--(BUSINESS WIRE)--Setpoint, the leading infrastructure provider for the credit industry, today announced the successful completion of its $31 million Series B funding round. 645 Ventures led ...
VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, announced that it has been accepted into the Total ...
VALENCIA, Calif., November 18, 2024--(BUSINESS WIRE)--SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today announced late-breaking ...
Hosted on MSN
How a one-minute jolt from the SetPoint implant offers new hope for autoimmune disease patients
The US Food and Drug Administration (FDA) recently approved a medical device that could bring new hope to patients suffering from rheumatoid arthritis (RA), a chronic autoimmune condition often ...
The US Food and Drug Administration (FDA) has approved SetPoint Medical’s implantable neuroimmune modulation device, SetPoint System, to treat moderate-to-severe rheumatoid arthritis (RA) in adults.
Setpoint, a real estate funding platform, acquired Resolute Diligence Solutions to support proptech and single-family rental re-engagement in the market, the firm said. Resolute Diligence Solutions is ...
Silicon Valley Bank (SVB), a division of First Citizens Bank, and lending partner Setpoint announced on Wednesday that they’re providing a $200 million warehouse facility to Austin-based mortgage tech ...
Fresh after getting the green light from the U.S. Food and Drug Administration, SetPoint Medical raises $140 million to market and distribute its rheumatoid arthritis treatment. SetPoint Medical Chief ...
Shortly after obtaining a green light from the FDA, SetPoint Medical announced $140 million in new funding to juice the commercialization of its neuromodulation implant for rheumatoid arthritis. The ...
Setpoint, a property tech startup that provides financing for real estate, has raised $43 million. The Series A round was led by US investing giant Andreessen Horowitz. We got an exclusive look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results